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By Letter of 11 July 1984, the President of the Council of the European Com-
munities requested the European Parliament to deliver an opinion pursuant to 
Article 43 of the EEC Treaty, on the proposal from the Commission of the European 
Communities to the Council for a Directive amending Directive 81/602/EEC concerning 
the prohibition of certain substances having a hormonal action and of any substances 
having a thyrostatic action. 
On 24 July 1984, the President of the European Parliament referred this proposal 
to the Committee on the Environment, Public Health and Consumer Protection as the 
committee responsible and to the Committee on Agriculture, Fisheries and Food for an 
opinion. 
At its meeting on 20 September 1984, the Committee on the Environment, Public 
Health and Consumer Protection appointed Mr COLLINS rapporteur. 
The committee considered the Commission's proposal and the draft report at its 
meetings of 21 November 1984, 19 December 1984, 28 February 1985 and 26 June 1985. 
At the Last meeting, the rapporteur withdrew the draft report and agreed to submit 
a revised text by the end of July. 
At its meeting of 19 September 1985, the committee considered the revised draft 
report and decided unanimously to recommend to Parliament that it approve the Com-
mission's proposal with the following amendments. 
The committee decided to reserve the right to propose to Parliament the applica-
tion of Rule 35(3), after having heard the opinion of the Commission. 
The committee then unanimously adopted the motion for a resolution as a whole. 
The following took part in the vote: Mrs Weber, chairman; Mr Collins, vice-
chairman and rapporteur; Mr Avgerinos <deputising for Mr Bombard), Mrs Banotti, 
Mr Cottrell, Mr Dalsass (deputising for Mr Alber), Mr Elliott (deputising for 
Mr Schmid), Mr Falconer (deputising for Mr Tognoli), Mrs van Hemeldonck (deputising 
for Miss Tongue), Mr Hughes, Mrs Jackson, Mr van der Lek, Mrs Lentz-Cornette, 
Mr Mertens, Mr Muntingh, Mr Nordmann, Mr Parodi, Mr Pearce, Mr Roelants du Vivier, 
Mr Schwalba-Hoth (deputising for Mrs Bloch von Blottnitz), Mr Sherlock, 
Mrs Squarcialupi, Mr Stevenson <deputising for Mr Vittinghoff) and Mrs Veil. 
The opinion of the Committee on Agriculture, Fisheries and Food is attached. 
The report was tabled on 2o September 1985. 
The deadline for tabling amendments to this report will be indicated in the 
draft agenda for the part-session at which it will be debated. 
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The Committee on the Environment, Public Health and Consumer Protection 
hereby submits to the European Parliament the following amendments to the 
C~ission's,proposal and motion for a resolution together with explanatory 
statement: 
P~oposal for a Council Directive amending Directive 81/602/EEC 
concerning the prohibition of certain substances having a hormonal 
action and of any substances having a thyrostatic action. 
TeKt proposed by the Commission 
of the European Communities 
Title 
Proposal for a Council Directive amending 
Directive 81/602/EEC concerning the pro-
hibition of certain substances having a 
hormonal action and of any substances 
having a thyrostatic action 
Amendments tabled by the Committee on 
I 
the Environment, Public Health and 
Consumer Protection 
Amendment No.1 
Title 
Proposal for a Council Regulation ~mending 
Directive 81/602/EEC concerning the pro-
hibit ion •••••• 
Recitals 1 to 6 unch~n9~0 
Recital 7 
Whereas, on scientific grounds, it appears 
that the use of Oestradiol 179, Testos-
terone and those derivatives which readily 
yield the parent compound on hydrolysis 
after absorption from the site of applica-
tion would not present any harmful effects 
to the health of the consumer nor harm the 
consumer by altering the characteristics 
of meat when used under the appropriate 
conditions as growth promoters in farm 
animals; whereas, in consequence, Member 
States may authorise their use for 
fattening purposes; 
5 
Amendment No.2 
Recital 7 
Delete and replace with: 
7 (a) Whereas since 1981 differences have 
existed in national regu~ations concerning 
Oestradiol 179, Progesterone, Testosterone, 
Zeranol and Trenbotone; considering that 
scientific information about these sub-
stances is far from complete and that con-
siderable doubt therefore exists about the 
desirability of their use and of their effect 
on human health; 
7 (b) Whereas, in particular, there seems to 
be doubt as to the effects on the immunity 
against various diseases of animals treate_d. -· 
with hormone cocktails and that this in turn 
may lead to an increased use of antibiotics; 
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rext proposed by the Comm1ss1on 
of the European Communities 
Recital 8 
Whereas approval of products containing 
authorised substances must comply with 
the relevant principles and criteria 
set out in Council Directive 81/851/EEC 
of 28 September 1981 on the approximation 
of the laws of the Member States6relating to veterinary medicinal products , and 
Council Directive 81/852/EEC of 28 Sep-
tember 1981 on the approximation of the 
laws of Member States relating to 
analytical, pharmaco-toxicological and 
clinical standards and protocols in 
respect of the tesfing of veterinary 
medicinal products ; 
Recital 9 
Whereas additional requirements as regards 
carrier substances, conditions of use and 
withdrawal periods must also be complied 
with; whereas a Community procedure 
within the Standing Veterinary Committee, 
set ~P by Council Decision of 15 October 
1968 , should be used to establish a list 
of products which may be approved and the 
conditions of their use, as well as to 
modify the list of authorised substances 
in the light of progress in scientific 
and technical knowledge; 
Amendments Labled by tne ~ommittee ott 
the EnvironMent, Public Health and 
Consumer Protection 
7 (c) Whereas, however, it will be very 
difficult, if not impossible, to carry out 
conclusive checks on the use of non-
authorised hormones so as to protect the 
safety of consuMe•~, 
7 (d) Whereas there is overproduction of 
meat and meat products in the European Com-
munity which adds considerably to the cost 
of the CAP: 
7 <e> Whereas the authorisation of the 
hormones Oestradiol 178, Testosterone and 
Progesterone, like Trenbolone and Zeranol, 
is neither necessary or nesirable, except 
for therapeutic purposes1; 
Amendment No.3 
Recital 8 
Delete 
Amendment No.4 
Recital 9 
Delete 
1
rhe terms "therapeutic purposes" as used throughout the text of this report should be 
understood to mean "action of remedial agents in disease" 
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Text proposed by the Commission 
of the European Communities 
Recital 10 
Whereas Member States may choose not to 
allow in their territory the marketing and 
administration to farm animals, for 
fattening purposes, of substances and 
products which may be authorised under the 
present Community rules, but must not raise 
any obstacle for human health reasons to 
the importation of animals, meat and meat 
products from other Member States where 
such substances and products have been 
authorised in accordance with Community 
rules; 
Amendments tabled by the Committee on 
the Environment, Public Health and 
Consumer Protection 
Amendment No.5 
Recital 10 
Delete 
Recital 11 unchanged 
Article 1 (1) 
Article 5 is replaced by the following: 
"Article 5 
1. By way of derogation from Article 2, 
Member States may authorise the 
administering to farm animals, for 
fattening purposes, of Oestradiol 
178, Testosterone and Progesterone 
and those derivatives which readily 
yield the parent compound on hydroly-
sis after absorption form the site of 
application." 
Article 1(1) 
Article 5 (2) 
2. Member States shall ensure that the 
aforementioned substances are: 
- only administered to farm animals by 
implantation which is Located in a 
part of the animal which must be 
discarded at slaughter, 
- only administered to animaLs which 
are identified at the time of 
implantation and that these animals 
Amendment No.6 
Article 1<1) 
New Article 5(1) to read: 
1. Without prejudice to Article 4(1) no 
derogation may be made from Article 2 
except insofar as Member States may 
~.l:Jthorise the administering to farm 
animals for therapeutic purposes of 
Oestradiol 178, Testosterone and 
Progesterone and those derivatives 
which readily yield the parent compound 
on hydrolysis after absorption from the 
site of application. 
Amendment No.7 
Article 1(1) 
Article 5(2) to read: 
2. Member States shall ensure that the 
afo~eme~tioned substances are only 
administered to farm animals that have 
been clearly identified, ~hat_!~e. 
do~i-~ _r:_e_c~~-~~--~!1.9. t~a!_ .!.~-~--§lnimal 
~0.Q.! . ..? .. L~l:J.9~-~e~_Q __ b~_for::._~.!~~ -~>p_i r_y 
of the delay period Laid down in 
-------·---- -- -·- -------- -- --- ------- ~~---.. ---
7 
application of subparagraph 3a. The 
substances must be ----adiiiiriT ster-e""don:!l 
by a veterinary surgeon or by a person 
acting under his direction. 
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Text proposed by the Commission 
of the European Communities 
are not slaughtered before the expiry 
of the delay period Laid down in 
application of subparagraph 3a) 
- administered by a veterinarian. 
Article 1(1) 
Article 5 
3 a) Before 1 April 1986 in accordance 
with the procedure Laid down in 
Article 16 and following the rele-
vant principles and criteria of 
Directives 81/851/EEC and 81/852/EEC 
there shall be established: 
-a List of products containing as 
active substances the substances 
referred to in paragraph 1 which 
may be approved for marketing and 
use in the Community, 
- the conditions of use of products 
contained in the abovementioned 
List of paragraph 2, in particular 
the delay period necessary and 
detailed provisions concerning the 
control of these conditions of use, 
- the means of identification of 
animals. 
Amendments tabled by the Committee on 
the Environment, Public Health and 
Consumer Protection 
Amendment No.8 
Article 1(1) 
Article 5 
3 a) Before 1 April 1986 in accordance 
with the procedure Laid down in 
Article 16 and following the relevant 
principles and criteria of Directives 
81/851/EEC and 81/852/EEC there shall 
be established: 
-a list of products containing as 
active substances the substances 
referred to in paragraph 1 which 
may be approved for marketing and 
use for therapeutic purposes in 
the Community, 
rest unchanged 
Article 5. 3(b) unchanged 
Amendment No.9 
Article 1(1) 
Article 5 
4. In order to take account d scientific 
and technical progress, the List of 
substances referred to in paragraph 
which may be administered to animals 
for fattening purposes, may be com-
pleted or amended in accordance with 
the procedure laid down in Article 16. 
Any substance which may be authorised: 
- must have a favourable effect on 
farm animal production, 
8 
Article 1(1) 
Article 5 
4. In order to take account of scientific 
and technical progress, the List of 
substances referred to in paragraph 
which may be administered to animals 
for therapeutic purposes, may be com-
pleted or amended •••••••• 
rest unchanged 
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Text proposed by the Commission 
of the European Communities 
Article 5(4) continuation 
- must not endanger human or animal 
health nor harm the consumer by 
altering the characteristics of 
farm animal products, 
- must comply with the relevant 
principles and criteria of 
Directives 81/851/EEC and 
85/852/EEC • 
Article 1(1) 
Article 5 
~. However, any decision concerning the 
possible inclusion of Trenbolone or 
Zeranol on the List shall be made by 
the Council, acting by a qualified 
majority on a proposal from the 
Commission, and in conformity with 
the other conditions laid down in 
paragraph 4. 
Amendments tabled by the Committee on 
the Environment, Public Health and 
Consumer Protection 
Amendment No.10 
Article 1(1) 
Article 5 
5. However, any decision concerning the 
possible inclusion of Trenbolone or 
Zeranol on the list shall be made by 
the Council, acting by a qualified 
majority on a proposal from the 
Commission, after consultation with 
the European Parliament, and in con-
formity with the other conditions 
Laid down in paragraph 4. 
Article 1 (2) ArticLes 7 to 11 unchanged 
Article 1 (2) 
Article 12 
1. Where examination as referred to in 
Article 11(3) has confirmed the 
presence of prohibited substances or 
of residues exceeding the maximum 
natural physiological Levels of 
authorised substances, the competent 
authorities shall be informed without 
delay of: 
a) all information needed to identify 
the origin of the animals, 
b) the result of the examination. 
Amendment No.11 
Article 1 (2) 
Article 12 
1.Where examination as referred to in Article 
11(3) has confirmed the presence of 
prohibited substances or of residues 
exceeding the maximum natural physiological 
Levels of authorised substances Cthes~ 
Levels to be published by the Commission), 
the competent authorities shall be informea 
without delay of: 
rest unchanged 
Article 12(2) unchanged 
Article 12(3) (a) and (b) unchanged 
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Text proposed by the Commission 
of the European Communities 
Article 12 
3 (c) if the examination reveals the 
presence of residues of authorised 
substances above the limits men-
tioned in paragraph 1, the 
slaughter of the animals concerned 
for human consumption shall be 
prohibited until it can be ensured 
that the amount of residue no 
Longer exceeds the permitted levels. 
This period may in no case be 
shorter than the delay period fixed 
for the substance in application of 
Article 5(3) (a). However, where 
it is ascertained that the con-
ditions of use laid down have not 
been complied with, the animals 
concerned shall be confiscated or 
destroyed. 
Amendments tabled by the Committee on 
the Environment, Public Health and 
Consumer Protection 
Amendment No.12 
Article 12 
3 (c) if the examination reveals the 
presence of residues of substances 
which have been authorised for use 
for therapeutic purposes above the 
limits mentioned in paragraph 1, tile 
slaughter of the animals concerned 
for human consumption shall be ••••• 
Articles12(3) (d) and 12(4) unchanged 
Articles 13 to 15 unchanged 
Article 16 
1. Where the procedure laid down in this 
Article is to be used, matters shall, 
without delay, be referred by the 
chairman, either on his initiative or 
at the request of a Member State, to 
He committee. 
2. Within the committee, the votes of 
Member States shall be weighted as 
provided in Article 148 of the Treaty. 
The chairman shall not vote. 
10 
Amendment No.13 
Article 16 
1. Where the procedure Laid down in this 
Article is to be used, the Commission 
shall transmit any proposed amendments 
to the European Parliament at Least 
three months or two part-sessions, 
whichever is the greater period, before 
the adoption of such amendments is 
required. 
2. Where the European Parliament informs 
the Commission that it wishes to give 
an opinion on such proposed amendments, 
their adoption shall be postponed for 
an additional three months or two part-
sessions, whichever is the greater 
period. 
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Text proposed by the Commission 
of the European Comffiunities 
3. The representative of the Commission 
shall submit a draft of the measures 
to be adopted. The committee shall 
deliver its opinion on such measures 
within a period to be determined by 
the chairman in keeping with the 
urgency of the question submitted for 
examination. Opinions shall be 
delivered by a majority of 45 votes. 
4. The Commiss;on shall adopt the measures 
and implement them immediately where 
they are in accordance with the opinion 
of the committee. Where they are not in 
accordance with the opinion of the com-
mittee or if no opinion is delivered, 
the Commission shall, without delay, 
propose to the Council the measures to 
be adopted. The Council shall adopt the 
measures by a qualified majority. If, 
within three months from the date on 
which a matter was referred to it the 
Council has not adopted any measures, 
the Commission shall adopt the proposed 
measures and implement them immediately, 
save where the Council has decided 
against these measures by a simple 
majority. 
Article 2 
Member States shall bring into force the 
Laws, regulations and administrative 
provisions necessary to comply with this 
Directive 
- not later than 1 July 1985 as regards 
the prohibition of the administration 
of Trenbolone and Zeranol to farm 
animals for fattening purposes, in 
application of Articles 2 and 5 of 
Directive 81/602/EEC, as amended by 
Article 1(1) of this Directive, 
- not Later than 1 July 1986 for the 
remaining provisions. They shall 
forthwith inform the Commission 
thereof. 
Amendments tabled by the Committee on 
the Environment, Public Health and 
Consumer Protection 
Article 16 (cont'd ••• > 
3. The Commission shall adopt the measures 
envisaged where they are in accordance 
with the opinion of the European Par-
Liament or if no such opinion is adopted. 
4. Where the measures envisaged are not in 
accordance with the opinion of the Euro-
pean Parliament, the Commission shall 
without delay propose to the Council the 
measures to be adopted. The Council 
shall act by a qualified majority. 
5. If, within three months of the proposals 
being submitted to it, the Council has 
not acted, the proposed measures shall 
be adopted by the Commission. 
11 
Amendment No.14 
Article 2 
Member States shall bring into force the 
Laws, regulations and administrative 
provisions necessary to comply with this 
Regulation 
- not later than 1 January 1986 
They shall forthwith inform the Commission 
thereof. 
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closing the procedure for consultation of the European Parlia~nt on the proposal 
fro. the Commission of the Eunopean C~nities to the Council for a directive 
aaending Directive 81/602/EEC concerning the prohibition of certain substances 
having a horeonal action and of any substances having a thyrostatic action 
The European Parlia•ent, 
- having regard to the proposal f~a- the Ca..ission to the Council <COM<84> 
295 fin.> 1, 
- having been consulted by the Council pursuant to Article 43 of the EEC Treaty 
<Doc.1-359/84), 
-having regard to its previous resolution concerning the use of anabolic agents 
2 
of 13 February 1981 , 
-having regard to the report of the Committee on the Environment, Public Health 
and Consumer Protection and the ooinion of the Coamittee on AgriculturP.~ Fi~heries 
and Food (Doc. A 2-100/85>, 
- having regard to the result of the vote on the Commission's proposal, 
A. whereas protection of public health and the interests of the consumer are major 
concerns of the Community; 
B. whereas it is essential therefore for the Community to produce food of the 
highest quality which will have no harmful effects on human health; 
C. whereas it is also essential for these standards to apply to food which is 
imported for consumption in the Community; 
D. considering that anabolics have been widely used in many countries for some 
30 years as therapeutic substances as well as growth promoters; 
E. considering that scientific information about these substances is far from 
complete and that considerable doubt therefore exists about the desirability 
of their use and of their effect on human health; 
F. whereas, in particular, there seems to be doubt as to the effects on the 
immunity against various diseases of animals treated with hormone cocktails 
and that this in turn may lead to an increased use of antibiotics; 
1
oJ No.C170 29.6.1984, p.4 and OJ No.C106, 27.4.1985, p.7 2
oJ No.C SO 9.3.1981, p.87 12 PE 95.615/fin. 
G. whereas since 1981 differences have existed in national regulations concerning 
Oestradiol 17 B, Progesterone, Testosterone, Zeranol and Trenbolone; 
H. whereas in certain countries of the Community it has recently been shown that 
existing regulations on the use of hormones have been flouted; 
I. whereas there is overproduction of meat and meat products in the European Com-
munity which adds considerably to the cost of the CAP; 
J. whereas the resultant uncertainty over the safety of these substances has had 
an adverse effect on consumer confidence; 
K. whereas the reactions of consumer organisations in the Member States have shown 
that those organisations reject the authorisation of hormones in meat production; 
L. whereas, however, it will be very difficult, if not impossible, to carry out 
conclusive checks on the use of non-authorised hormones so as to protect the 
safety of consumers; 
1. regrets that the Commission has taken so much time to draw up its present 
proposal and that the Scientific Committee has not yet produced its final 
report on zeranol and trenbolone; 
2. considers that in order to protect the consumer, uniform standards should be 
Laid down in all the Member States and that this should be done by means of a 
Regulation; 
3. regrets, however, that evidence seems to suggest that the use of stilbenes 
which were banned in 1981 is still widespread in certain Member States; 
4. considers therefore that any ban or restriction on the use of anabolics cannot 
be effective without a system of controls which is capable of enforcement; 
5. condemns the fact that without any consultation of the European Parliament, 
Council has recently adopted a Directive relating to the controls already 
referred to; 
6. welcomes the proposed ban on zeranol and trenbolone in view of the fact that 
their safety has not been conclusively proven; 
7. does not approve the proposed authorisation of the three natural hormones 
except for therapeutic purposes; 
8. recognises that there is considerable difficulty involved in checking whether 
such substances have been used because, where they have been properly adminis-
tered, the measurable residue concentrations are well within normal physiolo-
gical Limits relatively soon after application; 
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9. believes, therefore, that the permitted use of hormones for therapeutic pur-
poses must be strictly controlled and documented by means of the following: 
a) full records to be kept for every animal treated, these records to include 
the time and specification of the dose administered, the time of slaughter 
and the site of application or place of injection; 
b) the permitted substances to be made available only on the prescription of a 
veterinary surgeon; 
c) the use of the permitted substances to be allowed only by a veterinary 
surgeon or a person acting under his direction; 
10. approves the principle of random inspections at all levels of production for 
the purpose of detecting the illicit use of banned substances; 
11. believes, however, that there is a need for the Commission to produce more 
s)ecific proposals concerning the inspection procedure in order to ensure that 
the alleged misuse and abuse of anabolic agents in certain Member States does 
not continue; calls on the Commission to draw up such proposals immediately; 
12. calls on the Commission to publish details of the maximum natural physiological 
levels for the hormones authorised for therapeutic purposes; 
13. notes that the ban on artificial and natural hormones for fattening ~,.;;·poses t-Ji ll 
inevitably affect trade with third country suppliers of meat products; calls for 
. . 
immediate discussions to be held with the trading partners conc~rne~ uith a view 
to securing a total ban on imports of meat which have been treated with these 
substances; 
14. rejects the authorisation of artificial and natural hormones as growth 
promoters and notes that any further decision on Zeranol and Trenbolone will 
be subject to a Council decision; calls on the Council and Commission to 
consult Parliament if any further amendment is proposed as a result of the 
Scientific Committee's forthcoming report; 
15. requests the Commission to adopt, on the basis of Article 149, second paragraph 
of the EEC Treaty, the amendments which it has tabled to the Commission's 
proposal; 
16. instructs its President to forward to Council and Commission as Parliament's 
opinion, the Commiss1on's proposal as voted by the Parliament and the corres-
ponding resolution. 
14 PE 95.615/fin.. 
B 
EXPLANATORY STATEMENT 
Background 
1. In recent years there has been considerable consumer concern over the use 
of hormones in Livestock production. Questions have been raised as to 
whether the hormones used as anabolic agents have any harmful side-effects 
on the health of the consumer. Discussion of their safety came to a 
head in 1980 following the discovery in Italy of undissolved residue of 
Diethylstilboestrol (DES- an artificial hormone) in tinned baby food. 
The European Community's response to the public outcry which followed was 
to adopt a Directive1 in July 1981 banning the use of all substances 
having a thyrostatic action (including DES) and restricting most other 
hormones to therapeutic uses. However, existing national regulations 
were allowed to remain in force for five specific hormones: oestradiol 17 B, 
progesterone, testosterone, trenbolone and zeranol. The Commission agreed 
to consult its scientific committees and report back to the Council as 
soon as possible on the conclusions reached concerning these five hormones. 
2. A scientific working group on Anabolic Agents in Animal Production was set 
up under the chairmanship of Professor Lamming of the University of Notting-
ham. This group, along with the scientific committees, submitted its 
report in September 1982. There was general agreement that "when used 
under the appropriate conditions as growth promoters in farm animals", the 
three natural hormones, oestradiol 17 B, progesterone and testosterone, 
would not present any harmful effects to the health of the consumer. 
Indeed, the natural hormones used as anabolic agents are indistinguishable 
from the hormones already existing in the animals. As such, their pres-
ence at specific Levels is extremely difficult to detect. 
3. Before a final conclusion could be given on the two artificial hormones, 
zeranol and trenbolone, however, it was felt that additional information 
1 
was necessary concerning the toxicology of these substances. Further 
scientific data was received by the Lamming working group in January 1984. 
It is regrettable that the working group has still not produced any con-
clusions even though it has been in possession of this scientific data 
for over twelve months now. 
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3. (Cont'd) 
This delay is all the more regrettable for the fact that discussion of the 
problem of hormone use in meat production has been dragging on for more than 
3 years. This can do nothing to improve consumers' confidence in the products 
they are buying, nor can it improve retailers' confidence in the products they 
are selling. 
The Commission Proposal 
4. As a result of the findings of the scientific committees, the Commission 
proposes to authorize the use of oestradiol 17 B, testosterone and progesterone. 
With regard to zeranol and trenbolone, however, the Commission proposes to 
prohibit their use from 1 July 1985, until such time as their safety can be 
definitely established. 
5. It is the responsibility of the Standing Veterinary Committee to establish 
a list of products containing the three authorised substances and their 
conditions of use. New substances may be added to the List in the Light 
of progress in scientific and technical knowledge. As for zeranol and 
trenbolone, though, they may only be added to the List of permitted sub-
stances with the approval of Council based on a qualified majority. 
6. The Commission proposal also stipulates requirements for the administration 
of the authorised substances and Lays down the control procedure which 
Member States would have to implement to ensure that the provisions of the 
Directive are being complied with. 
The Health and Safety Aspects 
7. Whereas the metabolism of natural hormones has been thoroughly investigated 
and the residues in farm animals have been identified, not all the metabolites 
of the artificial hormones have yet been identified. There is not yet 
sufficient proof therefore to confirm that zeranol and trenbolone are not 
carcinogenic. The committee therefore approves of the Commission proposal 
to ban the use of these two hormones. 
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8. It must be noted, however, that there is no definite evidence condemning 
zeranol and trenbolone. Indeed, the pharmaceutical industry would argue 
that both products have been approved by <among other organisations) the 
FDA in the USA and the DHSS in the UK and are used in over 50 countries. 
As a result of worldwide use, there has been no reason to suspect safety 
problems and there are regular reviews of their safety, taking account of 
the most recent scientific data. Finally, it has been argued that the 
two artificial hormones present less of a danger through misuse and abuse 
than the natural hormones. There is no injectable form (recognised as 
being more dangerous than implants) and there is no economic advantage in 
using larger than recommended quantities. 
9. The consumers' organisations, on the other hand, believe that use of all 
hormones, both artificial and natural, should be banned. Their principal 
concern is that the system of controls is ineffective and open to abuse. 
Evidence we have received would suggest that the use of dangerous illegal 
substances such as DES and other stilbenes (banned in 1981) remains wide-
spread in certain Member States. It has also been alleged that injectable 
forms of permitted anabolics have been extensively used. 
deplorable and poses a potential threat to human health. 
This is obviously 
10. The problem of controls cannot be separated from any ban or restrictions on 
the use of hormones. To date, it is the ineffectiveness of enforcement 
procedures in certain Member States, rather than any lack of legislation 
which has allowed the practices mentioned above. This committee stresses 
therefore that it is essential that any system of controls be enforceable. 
It is unfortunate, in the committee's view, that Council should have recently 
adopted a directive on a control system, without consulting the European 
Parliament. 
11. As far as natural hormones are concerned, there is a definite problem here. 
Humans are exposed to variable levels of natural hormones in food from 
untreated animals. In fact, it has been shown that oestrogen levels in 
steers with implanted hormones are Lower than those occurring normally in 
untreated cycling and pregnant cattle. Since it is impossible to distinguish 
between natural hormones used as growth promoters and the same hormones 
existing already in the animals, it is questionable whether it would be 
feasible to carry out effective controls. The committee nonetheless feels 
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that in view of widespread disquiet among the public and in view of the 
fact that there is no demand on the part of consumers for the authorisation 
of hormones in meat production, these substances should not be authorised, 
except for therapeutic purposes. 
12. At very high dose Levels, the hormones oestradiol 17 B, progesterone and 
testosterone have been found to be carcinogenic. The question is whether 
the residues in animal products are at concentrations which would be 
carcinogenic to the consumer. Humans would need to consume enormous 
quantities of meat <estimates suggest levels far in excess of human body 
weight every day) for any danger to result from the residues of hormones. 
According to the scientific committees' reports, there is no danger of 
harmful side-effects when natural hormones are used under appropriate 
conditions. However, given that a doubt exists, and in view of the 
arguments outlined above, the committee stresses that these substances 
should be banned, at least until such time as it can be clearly shown 
that they are not only harmless but that their use produces desirable 
effects. 
13. We wish to stress, also, that their use for therapeutic purposes must be 
strictly controlled and documented. To this end, we would recommend that 
full records be kept for every animal treated. These records should include: 
specification of the dose administered; the place of implant; and the time 
of slaughter, and treated animals should be clearly identified. It is also 
essential that every implant is made in a part of the body that will be dis-
carded after slaughter. 
Furthermore, the Commission proposals should specifically prohibit all 
injectable forms of anabolics for fattening purposes. We cannot emphasise 
enough the importance of these records, in particular in relation to the need 
to ensure that animals are not slaughtered before the delay period has 
expired (a practice which, though not widespread, it has been suggested may 
still be used). 
14. Clearly, these controls would be more watertight if, as the Commission 
proposed, all treatment was carried out under the supervision of a veterinary 
surgeon. While agreeing that the substances should be made available only 
through proper veterinary surgeons, we feel it is not realistic to demand 
that only veterinarians should administer the substances. We have to 
recognise the unequal distribution of veterinary surgeons across the Community 
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with the result that some areas simply do not have enough veterinary 
surgeons to make the Commission proposal practicable. It should be suf-
ficient, therefore, for administration to be carried out by a veterinary 
surgeon or by a person acting under his direction. 
15. The system of checks, as proposed by the Commisison in Articles 7 - 11, 
has been criticised from all sides. From the pharmaceutical industry's 
and the veterinary associations' points of view, the proposals are 
"excessive", require disproportionately large resources and will not be 
enforceable. From the consumers' side comes the criticism that they are 
too general (for example, Article 8: "The Member States shall ensure that 
on-the-spot random checks ••• ") and do not make any precise statement about 
how to put them into practice. By Leaving the precise definition and func-
tioning of control programmes to Member States, it is argued, the Commission 
is opening the door to national disparities, and consequently, potential 
fraud. We would recommend therefore that the Commission draw up more 
specific proposals concerning the inspection procedure in order to ensure 
that the alleged misuse and abuse of anabolic agents in certain Member States 
does not continue. 
16. Article 12 of the Commission's proposal talks of "maximum natural physio-
Logical Levels of authorised substances". In view of the difficulty in 
distinguishing natural anabolic agents from existing hormones in the animal's 
body, we believe the Commission should publish more details of what these 
Levels are. The vagueness of the current wording again leaves the door 
open to abuse. 
Economic Aspects 
17. It has been argued by industry that the use of hormones as growth promoters 
has the following economic advantages: 
- increased yield through increased growth rate; 
- improved conversion rate of feed into meat; 
- ~n estimated 10% reduction in the necessary consumption of cereal-based 
feeds; 
a subsequent saving on land used for cereal crops. COn this latter 
point, it is important for us to note the beneficial impact this could 
have on the environment). 
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It is further argued that use of anabolics improves the ratio of Lean meat 
to fat, so invoking the quality argument. Apart from the advantages to 
the EEC, it is claimed that use of anabolics would also benefit the farmers, 
through reduced production costs, and eventually the consumers, through cut 
prices. 
18. Consumer groups completely refute the arguments concerning economic benefits, 
except insofar as use of hormones will benefit manufacturers. Firstly, 
because of the complications of the CAP pricing system, it is not necessarily 
true that consumers themselves will pay less for the meat they buy. More 
fundamentally, however, the question arises as to the usefulness of producing 
an estimated 450,000 extra tonnes of meat when Community stores of meat are 
at present in excess of 400,000 tonnes. <We would like to note, however, 
that this represents only a few days' consumption of meat in the Community). 
Indeed, national experts on the "beef meat" committee estimate that SO% of 
present stores are a direct result of the use of hormones in production. 
19. The committee acknowledges that use of hormones will increase the total 
amount of beef available and so increase the costs of the CAP through inter-
vention and storage. It also recognises, however, that the full effect of 
the milk quotas has not yet been realised and that these are likely to have a 
marked effect on Community meat production. 
20. It cannot be denied that the proposed ban on zeranol and trenbolone is Likely 
to cause some difficulties with regard to trade with third countries. Most 
of the major countries supplying the Community use substances that would be 
prohibited under the new Directive. It is essential, therefore, that the 
Community should enter immediately into negotiations with affected trading 
partners with a view to securing a total ban on imports of meat which have 
been treated with these substances. 
21. As regards intra-Community trade, it is clear that the amendment to the 
Directive is necessary. Under the original Directive, Member States were 
permitted to retain their national regulations concerning the five hormones 
in question here. Different attitudes to the substances existed across 
the EEC. As well as preventing free intra-Community trade, the different 
standards encouraged illegal use of substances where standards were perhaps 
more stringent than elsewhere. It is only by introducing uniform Community 
standards and controls that free trade can be guaranteed. 
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Future decisions concerning zeranol and trenbolone 
22. There is considerable disagreement over the procedure Laid down in the 
Commission's proposal for the possible inclusion in the future of trenbolone 
and zeranol on the list of authorised substances used for fattening pur-
poses. Industry argues that it is improper to judge such substances on 
anything other than scientific evidence. That this should be a decision 
of Council <Article 1.5) amounts to a political decision. For consumer 
groups on the other hand, the inclusion of any substance on the List should 
be subject to a unanimous Council decision, following consultations with 
both consumer organisations and the European Parliament. We would support 
the consumers' view insofar as we believe that consumers and the European 
Parliament should be consulted if any further amendment is proposed to the 
restrictions on the use of anabolic agents. 
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ANNEX 
The following groups and organisations have been consulted by the 
rapporteur during the drafting of the report: 
Bureau Europeen des Unions de Consommateurs (BEUC) 
British Veterinary Association 
Crown Chemicals Company Limited 
European Federation of Pharmaceutical Industries' Associations <EFPIA) 
European Feed Manufacturers Federation <FEFAC) 
Euroscot Meat <Exports) Ltd. 
Hoechst UK Ltd. 
Lilly/Elanco Products Company 
National Farmers Union (UK and Scotland) 
National Federation of Meat Traders 
The Retail Consortium (UK) 
Roussel UCLAF 
The Royal Environmental Health Institute of Scotland 
University of Glasgow Veterinary School 
PFMA - Pet Food Manufacturers' Association 
Cooperative Society 
Ministry for Agriculture, Ireland 
CECG - Consumers in the European Community Group 
Institution of Environmental Health Officers 
Hill & Knowlton International 
The Institute of Trading Standards Administration 
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OPl NION 
(Rule 101 of the Rules of Procedure) 
of the Committee on Agriculture, Fisheries and Food 
Draftsman: Mr. T.J. MAHER 
At its meeting on 30 October 1985, the Committee on Agriculture, Fisheries and 
Food appointed Mr T.J. Maher draftsman of the opinion. 
At its meeting of 28/29 March 1985, the committee decided to include in its 
opinion the motion for a resolution tabled by Mr Graefe zu Baringdorf pursuant 
to Rule 47 of the RuLes of Procedure on the implementation by the Commission 
of the European Communities of a ban on the use of fattening agents - such as 
natural and artificial hormones, antibiotics dnd penicillin -to protect 
consumers and promote systems of an1mal husoandry appropriate to the 
particular species in an environmentally acceptable and non-industrial system 
of agriculture, and the recognition that such a measure is compatible with the 
EEC Treaty (Doc. 1761/84). 
The committee cons1dered tne draft opinion at its meetings of 26/27 February, 
19/20 March and 28/29 March 1985. At the meeting of 15/16 May 1985 it adopted 
the conclusions by 28 votes to 9 with 3 abstentions. 
The following took part in the vote: Mr Tolman, chairman; Mr Eyraud, Mr Graefe 
zu Baringdorf and Mr Mouchel, vice-chairmen; Mr Maher, draftsman; Mr Bocklet, 
Mrs Castle, Mr Christensen, Mr Clinton, Mr Collins (deputizing for Mr Sutra), 
Mr Dalsass, Mr Elles (deputizing for Mr aattersby), Mrs Ewing (deputizing for 
Mr Musso), Mr Fruh, Mr Gatti, Mr Guarraci, Mr Happart, Mr Klinkenborg 
(deputizing for Mr Wettig), Mr Ligios (deputizing for Mr N. Pisoni), 
Mr MacSharry, Mr Maffre-Bauge, Mr Marek, Mr Mertens, Mr Morris, Mr Muhlen 
(deputizing for Mr Debatlsse), Mr Newens (deputizing for Mr Crawley), 
Mr B. Nielsen, Mr Pasty (deputiz~ng for Mr Fanton), Mr F. Pisani, 
Mr Pranchere, Mr Provan, Mr Romeos, Mr Rossi, Mrs Rothe, Mr Simmonds, Mr Spath 
(deputizing for Mr Sorgo), Mr Stavrou, Mr Thareau, Mr Vernimmen and Mr Woltjer. 
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1. Unaer Counc1L Directive 81/602/EEC of 31 July 19811, the Member States 
were required to prohibit the administering of substances having a 
thyrostatic act~on or substances having an oestrogenic, androgenic or 
gestagenic action to farm animals. The directive also banned the 
slaughtering or marketing of farm animals to which these substances had 
been administered and the marketing and processing of their meat. The 
Member States were further required to prohibit the marketing of stilbenes 
(synthetic compounds having an oestrogenic action), stilbene derivatives, 
their salts and esters and thyrostatic substances for administering to 
animals of all species. 
By way of o derogation from the general ban on the administering of the 
abovementioned substances, the directive authorizes the use of substances 
with an oestrogenic, androgenic or gestagenic action -excluding stilbenes 
and thyrostatic substances - for veterinary purposes, provided that the 
substance is administered by a veterinarian or a person under his direct 
responsibility. 
Since scientific investigations have not yet been completed, the directive 
excludes the natural hormones (sex hormones) Oestradiol, Progesterone, 
Testosterone and the synthetic compounds Trenbolone and Zeranol, which have 
a similar action, tram the ban, which means that these substances may still 
be administered to farm animals for fatten1ng purposes in the Member States 
concerned. The use of some of these substances is currently authorized for 
fattening purposes in Ireland, the United Kingdom and France. The 
maintenance of the ban in countries where their use is prohibited is not 
guaranteed. 
2. The Commission askea the Scientific Veterinary Committee, the Scientific 
Committee for AnimaL Nutrition and the Scientific Committee for Food to 
carry out the requisite tests to provide scientific information on the 
action of anabolic substances used to stimulate growth and on possible 
threats to public health. The three committees joined to form a Working 
Group on Anabolic Agents in Animal Production to coordinate their 
research. The results of its inquiries can be summarized as follows: 
2.1 The sex hormones Oestradiol, Testosterone, Progesterone, Trenbolone and 
Zcranol are anaboLic agents which can lead to increased feed conversion 
and hence prote1n deposition in the muscle fibres of farm animals 
although insufficient research has been done into the processes 
occurring inside and between molecules. Some Member States authorize 
the use of these substances for fattening purposes, provided that 
certain conoitions are fulfilled (implantation ot the hormones into a 
specific part ot the animal, e.g. ear or base of the ear, and 
oiscaraing of that part on slaughtering, observance of a delay period 
between implantation and slaughtering). 
loJ No. L 222, 7.8.1981, p. 32 
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2.2 The natural sex hormones Oestradiol, Testosterone and Progesterone 
regulate the anabolism, i.e. all the processes involving the exchange 
of substances and energy, in humans and animals. The hormones are 
rapidly broken down (mainly in the liver) with little or no biological 
effect. Since all animals produce these hormones naturally, they must 
be regarded as an unavoidable part of any foodstuff of animal origin. 
There is no qualitative means of determining whether hormonal residues 
of Oestradiol, Progesterone and Testosterone in farm animals are 
derived from hormones produced by the animal itself or were 
artificially administered. Similarly, there is no quantitative 
difference in residual hormone levels between animals which have 
received additional doses of hormones and those which have not, 
provided that the recommendations for administering these substances 
are followed. 
The Level of toxicity of hormone residues absorbed by humans as a 
result of the consumption of foodstuffs of animal origin is negligible 
since it is not possible for an effective concentration to reach the 
major hormone receptors in the human body, unlike the sex hormones 
actually produced within the body. 
The Working Group therefore concluded that administering the natural 
hormones Oestradiol, Progesterone and Testosterone presents no danger 
for human health, provided they are used correctly and in the 
appropriate form. 
2.3 The situation concerning the synthetic hormones Trenbolone and Zeranol, 
however, is somewhat different. These two substances are powerful 
growth stimulants in some ways similar to natural hormones but it has 
proved impossible to establish an exact 'no-hormone effect' dose and 
hence determine the level of toxicity as the animals used in the 
experiments reacted to minute doses and it was not possible to 
determine how far the changes were due to the administering of the two 
hormones. The working Group therefore reached no final conclusions on 
the use of Trenbolone and Zeranol and expressed the view that further 
research is necessary. 
3. This proposal for a directive1 aims to amend the existing Directive 
81/602/EEC concerning the prohibition of certain substances having a 
hormonal action and of any substances having a thyrostatic action, taking 
into account the Latest information on the effect of the hormones 
Oestradiol, Testosterone, Progesterone, Trenbolone and Zeranol. The 
purpose behind the adoption of Community provisions governing the use of 
hormonal substances in animal husbandry is to serve the interests of the 
producer and the consumer by protecting public health and by removing 
obstacles to trade in animals and meat which arise as a result of 
differences in the relevant Legislation in the Member States. The major 
changes contained in the proposal are as follows: 
loJ No. c 176, 29.6.1984, p. 4 
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3.1 Notwithstand1ng the generaL ban on administering hormones to farm 
animals for fattening purposes, the Memoer States may authorize the 
administering of the three natural hormones Oestradiol, Testosterone 
and Progest~rone ~rovided that the substance is administered through a 
part of the boay which must be discarded when the animal is 
slaughtered, that the animals concerned are clearly marked, that they 
are not slaughtered until the delay period to be established by the 
Standing Veterinary Committee has expired and that the substance is 
administereo by a veterinarian (new Article 5<2>>. 
3.2 Until 1 April 1986, the list of admissible products containing the 
three hormones, their marketing and use in individual cases and the 
means of identification of animals so treated will be Laid down in 
accordance with tne procedures of the Standing Veterinary Committee 
(new Article 5(3)(a)). 
3.3 New and as yet unapproved hormones for fattening purposes may only be 
approved provided that they have a favourable effect on all aspects of 
farm animal production, do not endanger human or animal health nor harm 
the consumer by altering the characteristics of animal products and 
comply with existing directives on veterinary medicines (new Article 
5(4), second subparagraph). 
Any decision on tne approval of the synthetic hormones Trenbolone and 
Zeranol will be taken by the Council acting by a qualified majority 
(new Article 5(5)). Until that time both substances are banned. 
3.4 Pursuant to the second paragraph ot Article 149 of the EEC Treaty, the 
Commission nas submitted an amendment1 to the present proposal for a 
directive to ensure that meat derived from animals treated with 
hormones bears an indication to that effect. The indication is to be 
reprodued clearly at all stages of preparation of meat until sale to 
the final consumer. 
(new Article Sa) 
3.5 The Memuer States must ensure that the basic ban on the administering 
of hormones and the conditions governing the use of the three natural 
hormones exemptea from this ban are observed. To this end, they must 
carry out offiCldl spot checks on manufacturing, handling, storage, 
transport, distribution and sale of the banned substances and other 
spot checks on agricultural holdings and in slaughterhouses. The 
samples from these spot checks are to be investigated by authorized 
Laboratories Cnew Articles 7, 8, 9, 10 and 11>. 
3.6 ~here these controls confirm the presence of hormonal residues of 
banned substances, the competent authorities must organize an 
investigation in the farm of origin to determine the reason for the 
presence of these residues. Any animals whose bodies are found to 
contain banned substances must be confiscated or destroyed and all 
stocks of banned hormones will be confiscated until such time as the 
appropriate sanctions have been decided (new Articles 12 and 13). 
1oJ No. c 106, 27.4.1985, p. 7 
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3.7 Article 2 of tnE ~resent proposal st1pu~~tes that the Member States 
must t&Ke tr.c a~~ropriate steps to ~ns~re tfidt the oan on the 
administering of irenbolone and Zeranol to farm animals for fattening 
purposes can come into force on 1 July 1985. Tne Member States must 
comply w'ith all other provisions conta1ned in this proposal for a 
directive no later than 1 July 1986. 
4. The Committee on Agriculture, fisheries and food has been keeping a 
sceptical eye on developMents in the field of additives used for fatteninq 
far. aniaals for some considerable time. Scientists have published the 
results of a vast amount of research proving that these additives lead to a 
considerable improveaent in the growth of fara animals and in the quality 
of meat, which is in the consumer's favour. However, the coeaittee also· 
shares the concern expressed by the general public and by aany consumer 
associations that abuse of these additives couid cqnceivably pose a threat 
to huun health. · · ·· ·• ·· · · · 
Of all the additives used for fattening farm animals, special importance i~ 
attached to hormones. These are substances which occur naturally in the 
bodies of humans and animals, although their concentration may differ. 
Administering hormones ·for therapeutic purposes raises no problems 
whatsoever, provided that these substances comply with existing directives 
on veterinary medicines and that the relevant safety provisions designed to 
protect the consumer (e.g. delay period prior to slaughter) are applied. 
However, the adainistering of regular doses to farm animals for fattening 
purposes and without medical grounds should only be authorized if there is 
proof that the hormone in question has no har11ful effects on human health, 
if abuse can be prevented and if there is a general economic advantage to 
be obtained by additional doses of hormones. In the committee's view, the 
three natural hormones Oestradiol, Progesterone and Testosterone, which the 
Commission proposes to approve, do not satisfy these conditions: 
4.1 The working group set up by the Commission to carry out research into 
the effect of these hormones concluded that these three hormones have 
no harmful effects on the health of consumers if administered as a 
growth stimulant to farm animals under appropriate conditions. More 
specifically, it expressed no reservations in connection with toxicity 
as the concentration of any hormone residues contained in the meat o.f 
farm animals would not be sufficient to provoke a reaction in the 
hormone receptors of the human body. As regards the absorption of 
hormone residues as a result of the consumption of meat, there is no 
appreciable difference between the meat of treated and untreated farm 
animals. The working group considers that the three natural hormones 
are harmless provided that they are used 'correctly'. Their incorrect 
use - e.g. overdoses or an inadequate delay period prior to slaughter -
creates certain risks for human beings as the Level of hormone residue 
in the meat may be too high. 
4.2 The Commission feels that the use of the three natural hormones can 
also be justified in economic terms. The administering of hormones 
leads to a significant increase in the daily growth rate and 
consequently in the carcass weight. Their main effect, however, is to 
bring about a significant improvement in the conversion of feed into 
meat. This aspect becomes all the more important when the availability 
of imported feed is restricted to promote the use of domestic feed 
(corn). This has a definite effect on the cost factor of meat 
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production as the Commission estimates show that using the same amount 
of feed, an agricultural holding can increase its production Levels by 
about 10X. It was also established that administering hormones can 
improve the composition of the carcass as regards the proportions of 
meat, fat and bones, thereby providing the consumer with a higher 
quality product. 
4.3 However, the committee takes the view that the report by the Scientific 
Group on Anabolic Agents in Animal Production cannot be considered 
exhaustive as regards the effects on human health and that further 
information therefore needs to be obtained before the substances 
concerned are permitted for fattening purposes. 
·~·.. .."!" ... 
5. In the ca-se-of· .. tn~ .:,sy'rit.hetic ho-rmones Trenbolon and Zeranol, the Scientific 
Working Party stated that since so11~ data on the •no-hormone effect' dose 
and toxicity were still missing, it could not give a final conclusion. 
The :commi.tt.e.e therefore takes the view that the administering of Trenbolone 
and Zeranol must be prohibite~.until a scientific evaluation of the missing 
data is available1. 
6. In the Light of the deliberations set out above, the Committee on 
Agriculture, Fisheries and Food calls on the Committee on the Environment, 
Public Health and Consumer Protection to take account of the following 
points in its motion for a resolution: 
CONCLUSI. ONS 
The Committee on Agriculture, Fisheries and Food, 
6.1 Takes the view that the report by the Scientific Group on Anabolic 
Agents in Animal Production cannot be considered exhaustive as regard~ 
the effects on human health and that further information therefore 
needs to be obtained; 
6.2 Rejects the Commission's proposal approving the use of three natural 
hormones : Oestradiol, Testosterone and Progesterone; 
6.3 Considers that a ban on the two synthetic hormones Trenbolone and 
Zeranol can be justified until the scientific evaluation of their 
•no-hormone-effect' dose and toxicity has been completed. 
6.4 Does not endorse the proposal for a Council directive amending 
Directive 81/602/EEC concerning the prohibition of certain substances 
having a hormonl action and of any substances having a thyrostatic 
action, and calls on the Commission to submit a proposal amending this 
directive with a view to the general prohibition in all the Member 
States of the Community having a hormonal or thyrostatic action. 
1rhe committee therefore endorsed the motion for a resolution tabled by 
Mr Graefe zu Baringdorf pursuant to Rule 47 of the Rules of Procedure 
(Doc. 2-1761/85) and calling for a ban on all such substances. 
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